PMC Articles for MedGen (Select 353872) - PMC

Links from MedGen

Items: 1 to 20 of 188

<< First< Prev

Page of 10

Select item 112178631.

Clinical characteristics and treatment patterns of patients with NTRK fusion–positive solid tumors: A multisite cohort study at US academic cancer centers

Connor Willis, Trang Au, Andre Hejazi, Cassia Griswold, Matthew B. Schabath, Jonathan Thompson, Jyoti Malhotra, Noah Federman, Gilbert Ko, Sreevalsa Appukkuttan, Neil Warnock, Sheldon X. Kong, Brian Hocum, Diana Brixner, David Stenehjem

J Manag Care Spec Pharm. 2024 Jul; 30(7): 672–683. doi: 10.18553/jmcp.2024.30.7.672

PMCID:: PMC11217863

Abstract Article PDF–314K

Select item 111658972.

Inflammatory rhabdomyoblastic tumor, pheochromocytoma, and pulmonary hamartoma in a patient with neurofibromatosis type 1: a case report

Otto Jokelainen, Heidi Myllykangas, Katri Rajala, Jarkko Marttila, Reijo Sironen

Diagn Pathol. 2024; 19: 78. Published online 2024 Jun 11. doi: 10.1186/s13000-024-01503-3

PMCID:: PMC11165897

Abstract Article PDF–4.3M

Select item 110877483.

β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells

Previn Dutt, Nasir Haider, Samar Mouaaz, Lauren Podmore, Vuk Stambolic

Proc Natl Acad Sci U S A. 2024 May 7; 121(19): e2300606121. Published online 2024 Apr 29. doi: 10.1073/pnas.2300606121

PMCID:: PMC11087748

Abstract Article PDF–1.6M

Select item 110686664.

Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands

Irene Santi, Heleen Vellekoop, Matthijs M Versteegh, Simone A Huygens, Winand N. M. Dinjens, Maureen Rutten-van Mölken

Mol Diagn Ther. 2024; 28(3): 319–328. Published online 2024 Apr 14. doi: 10.1007/s40291-024-00704-2

PMCID:: PMC11068666

Abstract Article PDF–857K

Select item 110376775.

Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability

Filiberto Belli, Flavio Arienti, J. Sulé-Suso, C. Clemente, Luigi Mascheroni, Alessandro Cattelan, Cristina Santantonio, Gian Francesco Gallino, Cecilia Melani, Stefania Rao, Mario P. Colombo, Michele Maio, Natale Cascinelli, G. Parmiani

Cancer Immunol Immunother. 1997 Jun; 44(4): 197–203. doi: 10.1007/s002620050373

PMCID:: PMC11037677

Abstract Article PDF–943K

Select item 109957096.

An aggressive case of a thoracic undifferentiated SMARCA4‐deficient tumor with extensive pleural involvement

Paul F. Hanona, Daniel Ezekwudo, Joseph Fullmer, Timothy Allen, Ishmael Jaiyesimi

Thorac Cancer. 2024 Apr; 15(10): 847–851. Published online 2024 Feb 23. doi: 10.1111/1759-7714.15230

PMCID:: PMC10995709

Abstract Article PDF–1.8M

Select item 109913297.

Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8⁺ T cell infiltration

Masaya Kanahori, Eijiro Shimada, Yoshihiro Matsumoto, Makoto Endo, Toshifumi Fujiwara, Akira Nabeshima, Takeshi Hirose, Kengo Kawaguchi, Ryunosuke Oyama, Yoshinao Oda, Yasuharu Nakashima

Br J Cancer. 2024 Apr 20; 130(7): 1083–1095. Published online 2024 Jan 30. doi: 10.1038/s41416-024-02576-z

PMCID:: PMC10991329

Abstract Article PDF–3.0M

Select item 108985428.

Successful Crizotinib-targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma

Megan L. Wood, Julie C. Fanburg-Smith, James M. Brian, Jason C. White, Jonathan L. Powell, Andrew S. Freiberg

J Pediatr Hematol Oncol. 2024 Mar; 46(2): e184–e187. Published online 2023 Dec 15. doi: 10.1097/MPH.0000000000002777

PMCID:: PMC10898542

Abstract Article PDF–364K

Select item 108019369.

Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma

Lili Liu, Lan Li, Yi Ding, Fangzhou Kong, Wenfa Mo, Hongtao Ye, Danhua Shen

Diagn Pathol. 2024; 19: 19. Published online 2024 Jan 22. doi: 10.1186/s13000-024-01443-y

PMCID:: PMC10801936

Abstract Article PDF–2.3M

Select item 1070956710.

A novel feature selection algorithm for identifying hub genes in lung cancer

Tehnan I. A. Mohamed, Absalom E. Ezugwu, Jean Vincent Fonou-Dombeu, Mohanad Mohammed, Japie Greeff, Murtada K. Elbashir

Sci Rep. 2023; 13: 21671. Published online 2023 Dec 7. doi: 10.1038/s41598-023-48953-1

PMCID:: PMC10709567

Abstract Article PDF–3.2M

Select item 1063883011.

Crizotinib combined with bronchoscopic interventional treatment in ALK-positive inflammatory myofibroblastic tumor of left main stem bronchus: a case report

Peng Zhang, Chenchen Wang, Zechao Lv, Mingxiang Du, Ruixin Xu

J Cardiothorac Surg. 2023; 18: 318. Published online 2023 Nov 10. doi: 10.1186/s13019-023-02427-7

PMCID:: PMC10638830

Abstract Article PDF–1.5M

Select item 1063259812.

Advances in treatment of alveolar soft part sarcoma: an updated review

Tomohiro Fujiwara, Toshiyuki Kunisada, Eiji Nakata, Kenji Nishida, Hiroyuki Yanai, Tomoki Nakamura, Kazuhiro Tanaka, Toshifumi Ozaki

Jpn J Clin Oncol. 2023 Nov; 53(11): 1009–1018. Published online 2023 Aug 25. doi: 10.1093/jjco/hyad102

PMCID:: PMC10632598

Abstract Article PDF–967K

Select item 1062214313.

Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study

Xiaohao Ruan, Da Huang, Yongle Zhan, Jingyi Huang, Jinlun Huang, Ada Tsui-Lin Ng, James Hok-Leung Tsu, Rong Na

eLife. 2023; 12: e86379. Published online 2023 Nov 2. doi: 10.7554/eLife.86379

PMCID:: PMC10622143

Abstract Article PDF–1.6M

Select item 1059050014.

Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy

Ruihe Lin, Atrayee Basu Mallick, Zi-Xuan Wang, Scot Andrew Brown, Bo Lu, Wei Jiang

Diagn Pathol. 2023; 18: 116. Published online 2023 Oct 21. doi: 10.1186/s13000-023-01400-1

PMCID:: PMC10590500

Abstract Article PDF–1.9M

Select item 1058252715.

Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients

Yoon Jin Cha, Chung Lee, Bio Joo, Kyung A Kim, Choong-kun Lee, Hyo Sup Shim

Cancer Res Treat. 2023 Oct; 55(4): 1087–1095. Published online 2023 Jun 15. doi: 10.4143/crt.2023.682

PMCID:: PMC10582527

Abstract Article PDF–1.9M

Select item 1052459016.

FDA Approval Summary: Selpercatinib for the treatment of advanced RET fusion-positive solid tumors

Elizabeth S. Duke, Diana Bradford, Michelle Marcovitz, Anup K. Amatya, Pallavi S. Mishra-Kalyani, Emily Nguyen, Lauren S. L. Price, Jeanne Fourie Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E. Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J. Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh

Clin Cancer Res. Author manuscript; available in PMC 2024 Mar 15.

Published in final edited form as: Clin Cancer Res. 2023 Sep 15; 29(18): 3573–3578. doi: 10.1158/1078-0432.CCR-23-0459

PMCID:: PMC10524590

Abstract Article PDF–478K

Select item 1048322017.

ALK-rearranged Mesenchymal Neoplasms: A Report of 9 Cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors

Josephine K. Dermawan, Sara E. DiNapoli, Kerry A. Mullaney, Purvil Sukhadia, Narasimhan P. Agaram, Brendan C. Dickson, Cristina R. Antonescu

Genes Chromosomes Cancer. Author manuscript; available in PMC 2024 Feb 1.

Published in final edited form as: Genes Chromosomes Cancer. 2023 Feb; 62(2): 75–84. Published online 2022 Oct 7. doi: 10.1002/gcc.23097

PMCID:: PMC10483220

Abstract Article PDF–2.5M

Select item 1047635218.

Pulmonary inflammatory leiomyosarcoma represents a potential diagnostic pitfall of DNA methylation-based classification of sarcomas: a case report

Takahiro Shibayama, Kaishi Satomi, Ryota Tanaka, Akihiko Yoshida, Kiyotaka Nagahama, Akimasa Hayashi, Takashi Hibiya, Kazuharu Suda, Masachika Fujiwara, Junji Shibahara

BMC Pulm Med. 2023; 23: 324. Published online 2023 Sep 4. doi: 10.1186/s12890-023-02624-z

PMCID:: PMC10476352

Abstract Article PDF–1.5M

Select item 1046436519.

Anlotinib affects systemic lipid metabolism and induces lipid accumulation in human lung cancer cells

Zhongling Zhu, Shan Xu, Jing Ren, Teng Jiang, Cai Zhang, Zhao Yan

Lipids Health Dis. 2023; 22: 134. Published online 2023 Aug 23. doi: 10.1186/s12944-023-01907-y

PMCID:: PMC10464365

Abstract Article PDF–6.4M

Select item 1035688720.

NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma

Moritz Schmidt, Sven Mattern, Stephan Singer, Martin Schulze, Saskia Biskup, Patrick Krumm, Ulrich M. Lauer, Lars Zender, Clemens Hinterleitner, Martina Hinterleitner

J Cancer Res Clin Oncol. 2023; 149(9): 6753–6757. Published online 2023 Feb 7. doi: 10.1007/s00432-023-04598-1

PMCID:: PMC10356887

Abstract Article PDF–567K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 188

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity